Antifungal agents for onychomycoses

被引：18
|
作者：
Javier Carrillo-Munoz, Alfonso [1 ]
Tur-Tur, Cristina [2 ]
Manuel Hernandez-Molina, Juan [3 ]
Santos, Patricia [4 ]
Cardenes, Delia [1 ]
Giusiano, Gustavo [5 ]
机构：
[1] Assoc Catalana Intel Ligencia Artificial ACIA, Dept Microbiol, Barcelona, Spain
[2] Ctr Atencio Primaria CAP Manso, Serv Diagnost Imatge SDPI, Barcelona, Spain
[3] Hosp Carlos Haya, Microbiol Serv, Malaga, Spain
[4] Hosp Pediat JP Garrahan, Microbiol Serv, Buenos Aires, DF, Argentina
[5] Univ Nacl Nordeste, Inst Med Reg, Dept Micol, Resistencia, Chaco, Argentina
来源：
REVISTA IBEROAMERICANA DE MICOLOGIA | 2010年 / 27卷 / 02期
关键词：
Onychomycosis; Antifungal drugs; Yeasts; Dermatophytes; IN-VITRO ACTIVITY; CICLOPIROX NAIL LACQUER; DERMATOPHYTE TOENAIL ONYCHOMYCOSIS; ORAL TERBINAFINE; COMBINATION THERAPY; TREATMENT OPTIONS; SCOPULARIOPSIS-BREVICAULIS; PHARMACOECONOMIC ANALYSIS; TREAT ONYCHOMYCOSIS; TOPICAL AMOROLFINE;
D O I：
10.1016/j.riam.2010.01.007
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Nail fungal infections are considered one of the major dermatological problems due to their high rate of therapeutic failure, management and treatment difficulties. Long-term treatments, inadequate therapies, mycological misdiagnosis and follow-up, secondary alterations of the nail, and resistant microorganisms, are some of the causes of these complications. Although the discovery of new antifungal agents has provided some effective molecules, none of the current available drugs are totally effective. It is important to continue researching in this field to provide new antifungal agents and combined therapies. (C)09 Revista Ieroamericana de Micologia. Published by Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码：49 / 56
页数：8
相关论文
共 50 条
12345